Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radient Technologies Inc RDDTF


Primary Symbol: V.RTI.H

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Comment by investryon Aug 28, 2019 1:46pm
123 Views
Post# 30075648

RE:RE:RE:RE:Next news release...

RE:RE:RE:RE:Next news release...Fake news. They are building. Quote from MD&A:

"The Company is in the process of building out large-scale cannabis processing capacity in Germany. Initial plans are to establish production levels similar to Edmonton I within a leased, existing facility. This will allow the Company to rapidly establish a market presence in line with domestic cannabis cultivation scale. Ultimately, the Company will expand this facility to production comparable to Edmonton III (currently under construction in Canada). The Company anticipates initial capacity will be commissioned in the second half of calendar 2020. Designs for the European facilities are focused in the near-term on the consistent, industrial-scale delivery of cannabinoid derivatives and formulations, manufactured in the European Union good manufacturing practice (“EU GMP”) environment. In July 2018, the European cannabis market was estimated by the strategic consultancy firm, Prohibition Partners, to be worth "

"
In the coming months, Radient intends to expand its product offerings to encompass crude extracts, refined oils and white label formulations. The intent is to provide the Company’s clients with multiple product touch points, while moving up the value chain. This will be a part of the Company’s planned capital outlays in Edmonton III and Germany to create value added products in addition to processing extracts for Licensed Producers."
<< Previous
Bullboard Posts
Next >>